Zhendong Shi

Tianjin Medical University

H指数:25

被引数:2,460

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Dynamic Evolution of HER2 Expression Following Neoadjuvant Therapy and Its Association With Treatment Response and Prognosis in Breast Cancer: A Large-Scale Retrospective Study

新辅助治疗后续存HER2表达动态演变及其与治疗反应和预后的相关性：一项大规模回顾性研究

World Journal of Surgery

IF2.5

2026-05-010

PRE

Personalized prediction of pathological complete response in breast cancer neoadjuvant therapy: a nomogram combining quantitative MRI biomarkers and molecular subtypes

乳腺癌新辅助治疗中病理完全缓解的个性化预测：一种结合定量MRI生物标志物和分子亚型的列线图

Frontiers in Oncology

IF3.3

2025-09-300

OAAI

Co-encapsulation of granzyme B and perforin in nanocapsules for tumour therapy: biomimicking immune cells

JOURNAL OF CONTROLLED RELEASE

IF11.5

2024-05-012

PRE

Chemotherapy-elicited exosomal miR-378a-3p and miR-378d promote breast cancer stemness and chemoresistance via the activation of EZH2/STAT3 signaling

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

IF12.8

2021-04-06108

OAAI

Over-Expression of Centromere Protein U Participates in the Malignant Neoplastic Progression of Breast Cancer

FRONTIERS IN ONCOLOGY

IF3.3

2021-03-235

OAAI

Chidamide Combined With Doxorubicin Induced p53-Driven Cell Cycle Arrest and Cell Apoptosis Reverse Multidrug Resistance of Breast Cancer

FRONTIERS IN ONCOLOGY

IF3.3

2021-03-0218

OAAI

Centromere protein U (CENPU) enhances angiogenesis in triple-negative breast cancer by inhibiting ubiquitin-proteasomal degradation of COX-2

CANCER LETTERS

IF10.1

2020-07-0129

PREAI

Long non-coding RNA SNHG22 facilitates the malignant phenotypes in triple-negative breast cancer via sponging miR-324-3p and upregulating SUDS3

CANCER CELL INTERNATIONAL

IF6

2020-06-1728

OAAI

A novel Granzyme B nanoparticle delivery system simulates immune cell functions for suppression of solid tumors

THERANOSTICS

IF13.3

2019-01-0140

OAAI

Correlation of radiotherapy with prognosis of elderly patients with hormone receptor-positive breast cancer according to immunohistochemical subtyping

免疫组化分型分析老年激素受体阳性乳腺癌患者放疗与预后的相关性

CHINESE JOURNAL OF CANCER RESEARCH

IF6.3

2019-01-014

MiR-340 Inhibits Triple-Negative Breast Cancer Progression by Reversing EZH2 Mediated miRNAs Dysregulated Expressions

MiR-340通过逆转EZH2介导的miRNAs异常表达抑制三阴性乳腺癌进展

JOURNAL OF CANCER

IF3.2

2017-01-0136

OAAI

DNMT1 and EZH2 mediated methylation silences the microRNA-200b/a/429 gene and promotes tumor progression

DNMT1和EZH2介导的甲基化沉默microRNA-200b/a/429基因并促进肿瘤进展

CANCER LETTERS

IF10.1

2015-04-01172

PREAI

SNORD76, a box C/D snoRNA, acts as a tumor suppressor in glioblastoma

SCIENTIFIC REPORTS

IF3.9

2015-02-2654

OAAI

ICAT inhibits glioblastoma cell proliferation by suppressing Wnt/β-catenin activity

CANCER LETTERS

IF10.1

2015-02-0144

PREAI

EZH2 is a negative prognostic factor and exhibits pro-oncogenic activity in glioblastoma

CANCER LETTERS

IF10.1

2015-01-0185

PREAI

BASI, A Potent Small Molecular Inhibitor, Inhibits Glioblastoma Progression by Targeting microRNA-mediated β-Catenin Signaling

CNS NEUROSCIENCE & THERAPEUTICS

IF5

2014-05-0911

A lentivirus-mediated miR-23b sponge diminishes the malignant phenotype of glioma cells in vitro and in vivo

ONCOLOGY REPORTS

IF3.9

2014-02-0461

OAAI

Star-branched amphiphilic PLA-b-PDMAEMA copolymers for co-delivery of miR-21 inhibitor and doxorubicin to treat glioma

BIOMATERIALS

IF12.9

2014-02-01179

PREAI

Blockage of a miR-21/EGFR regulatory feedback loop augments anti-EGFR therapy in glioblastomas

CANCER LETTERS

IF10.1

2014-01-0182

PRE

AC1MMYR2, an Inhibitor of Dicer-Mediated Biogenesis of Oncomir miR-21, Reverses Epithelial-Mesenchymal Transition and Suppresses Tumor Growth and Progression

CANCER RESEARCH

IF16.6

2013-09-02177

Zhendong Shi

个人简介

教育背景

工作经历

荣誉奖项

研究方向